Literature
Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Focused Guidelines on Acute Heart Failure in Children
Evidence suggests updated Canadian guidelines provide structured recommendations for pediatric acute heart failure management, addressing diagnostic approaches including cardiac MRI and BNP testing, along with therapeutic strategies for inotropic support and mechanical circulatory assistance. Worth noting the guidelines specifically address timing considerations for ventricular assist devices and ECMO with left atrial decompression in children. Signal observed for systematic evidence-based approaches to managing acute decompensation in complex congenital heart disease populations.
These recommendations are on the basis of systematic evidence reviews, the evidence to decision framework, and expert consensus, with detailed methodology and supporting evidence provided...
Relevance: Directly addresses pediatric heart failure management relevant to HLHS, Fontan, and single ventricle populations in the practice profile, with therapeutic guidance for formulary agents including inotropes.
PMID: 41951283The Canadian journal of cardiology(Journal Article) Literature
Development and validation of an interpretable machine learning model for predicting medium-to-giant coronary aneurysms in Kawasaki disease
Signal observed for machine learning prediction of medium-to-giant coronary aneurysms in Kawasaki disease using seven clinical features including time to diagnosis, monocyte percentage, and inflammatory markers. Evidence suggests the model achieved moderate predictive performance with AUC 0.732 internally and 0.689 in external validation across 2,777 patients. Worth noting the model incorporates routine clinical data available in electronic medical records for early risk stratification.
This study presents an interpretable ML model to predict MGCAA risk in KD using routine clinical data, supporting clinical risk assessment.
Relevance: Directly relevant to Kawasaki disease diagnosis in the practice profile, providing predictive tools for coronary artery aneurysm risk assessment in pediatric patients.
PMID: 41953021Frontiers in immunology(Journal Article) Literature
Melatonin effects on the left ventricular function in neonates with persistent pulmonary hypertension
Evidence suggests melatonin administration in neonates with persistent pulmonary hypertension demonstrated improved left ventricular function parameters and reduced biomarkers of oxidative stress including NT-proBNP. Signal observed for earlier weaning from mechanical ventilation and shorter hospital stays in the melatonin group compared to standard therapy alone. Worth noting the potential cardioprotective mechanisms in hypoxic pulmonary hypertension affecting cardiac performance.
• Melatonin's antioxidant and vasodilatory properties may serve as an adjunctive therapy in PPHN and enhance myocardial protection from the hypoxic effect of PPHN.
Relevance: Addresses pulmonary hypertension research interest with focus on cardiac function outcomes in neonates, though melatonin is not part of the current formulary profile.
PMID: 41954764European journal of pediatrics(Journal Article) Literature
Clinical Advances in Heart Failure with Preserved Ejection Fraction: A Systematic Review of Therapeutic and Mechanistic Evidence
Signal observed for emerging therapeutic approaches in heart failure with preserved ejection fraction, including SGLT2 inhibitors and novel agents like finerenone and GLP-1/GIP receptor agonists. Evidence suggests HFpEF now represents over 50% of heart failure diagnoses with improved diagnostic accuracy through advanced echocardiography and biomarkers. Worth noting the focus on phenotypic classification and personalized therapeutic strategies, though this addresses adult rather than pediatric populations.
However, further incorporation into clinical guidelines and validation through real-world evidence remain necessary.
Relevance: Related to heart failure research interest but focuses on adult HFpEF rather than pediatric single ventricle, Fontan, or other congenital heart disease populations in the practice profile.
PMID: 41953528Vascular health and risk management(Journal Article)